Phenotypic and Molecular Detection of Carbapenemase-Producing Acinetobacter baumannii Strains from Clinical Specimens in Dezful Teaching Hospital

Deihim Behnaz, Maryam Khorramizadeh

Abstract


Nowadays, antibiotic resistance in bacteria has become a global problem. Therefore, the identification of resistant strains of bacteria has attracted special attention in a pursue to choose more effective treatment solutions. One of the most common mechanisms of resistance is the production of carbapenemase enzyme in Acinetobacter baumannii. This present study aimed to detect carbapenemase-producing strains by phenotypic and molecular methods in clinical specimens collected in Ganjavian Hospital of Dezful between June 2021 and May 2022. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion and Etest assay, while the extended-spectrum beta-lactamase production (ESBLs) and Metalobetalactamases (MBLs) were detected by combined disk method using ceftazidime and ceftazidime/clavulanic acid disks and imipenem and imipenem /EDTA disks, respectively. Molecular detection of blaIMP, blaSPM, blaOXA-23, and blaOXA-24, blaOXA-58, blaGES genes was performed. Of a total of 54 strains, the highest resistance rate was for cephalosporins (98.1%), and ciprofloxacin (94.2%), in contrast to minocycline (13%). ESBL and MBL producers were 26% and 80%, respectively. All isolates had intermediate resistance against colistin. The most prevalent gene in the carbapenem-resistant A. baumannii (CRAB) was blaOXA-23, followed by blaOXA-24, blaGES, blaIMP, and blaOXA-58 genes. Present report highlights the existence of CRAB and intermediate resistance to colistin and also the co-existence of several genes from different carbapenemase classes in this region. Therefore, resistant strains should be identified promptly and specific treatment protocols should be devised to control the dissemination of resistance genes in therapeutic settings.


Keywords


A. baumannii; Carbapenem resistance; Carbapenemase; Genotyping

Full Text:

PDF

References


  1. Mahon CR LD, Manuselis G. Textbook of D M. 6th edition. Pennsylvania: Elsevier Mosby; 2016.
  2. Kurihara MNL, Sales ROd, Silva KEd, Maciel WG, Simionatto S. Multidrug-resistant Acinetobacter baumannii outbreaks: A global problem in healthcare settings. Rev Soc Bras Med Trop. 2020;53. doi:10.1590/0037-8682-0248-2020
  3. Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300. doi: 10.4103/joacp.JOACP_349_15.
  4. Kadri SS. Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers. Crit Care Med. 2020;48(7):939–45. doi:10.1097/CCM.0000000000004371
  5. Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10):e000306. doi:10.1099/mgen.0.000306
  6. Ko KS, Choi Y, Lee J-Y. Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii. Precis Future Med. 2017;1(4):159–67. DOI: 10.3390/ijms22020576.
  7. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482–501. doi:10.3934/microbiol.2018.3.482
  8. Codjoe FS, Donkor ES. Carbapenem resistance: a review. Medical Sciences. 2018;6(1):1. doi: 10.3390/medsci6010001.
  9. Kock MM, Bellomo AN, Storm N, Ehlers MM. Prevalence of carbapenem resistance genes in Acinetobacter baumannii isolated from clinical specimens obtained from an academic hospital in South Africa. South Afr J Epidemiol Infect. 2013;28(1):28–32. doi 10.1080/10158782.2013.11441516.
  10. Tehrani KH, Martin NI. β-lactam/β-lactamase inhibitor combinations: an update. MedChemComm. 2018;9(9):1439–56. doi: 10.1039/c8md00342d.
  11. Li J, Li Y, Cao X, Zheng J, Zhang Y, Xie H, Li C, Liu C, Shen H. Genome-wide identification and oxacillinase OXA distribution characteristics of Acinetobacter spp. based on a global database. Front Microbiol. 2023;14:1174200. doi:10.3389/fmicb.2023.1174200
  12. Forbes BA, Sahm D, Weissfeld A. Diagnostic Microbiology, Bailly and Scott. 12th ed. London: Mosby Co; 2007. p. 842–55.
  13. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119-23. doi: 10.1016/j.diagmicrobio.2010.12.002
  14. Amin M, Navidifar T, Shooshtari FS, Goodarzi H. Association of the genes encoding metallo-β-lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2019;12:1171. doi: 10.2147/IDR.S196575
  15. Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of bla OXA-23 and bla NDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017;6(1):1–7. doi: 10.1186/s13756-017-0180-5
  16. Guckan R, Kilinc C, Demir A, Capraz A, Yanik K. Antimicrobial susceptibility of Acinetobacter baumannii complex isolated from different clinical samples in a tertiary care hospital. J Antibiot Res. 2015;1(1):1–5.
  17. Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013;5(3):195–202.
  18. Qureshi ZA, Hittle LE, O’Hara JA, Rivera JI, Syed A, Shields RK, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60(9):1295–303. doi: 10.1093/cid/civ048
  19. Leungtongkam U TR, Tasanapak K, Sitthisak S. Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii. PLoSON. 2018;13(12):e0208468. doi: 10.1371/journal.pone.0208468
  20. Lin M. F. LCY. Antimicrobial Resistance in Acinetobacter baumannii: From Bench to Bedside. World J Clin Cases. 2014;2(12):787–814. doi: 10.12998/which.v2.i12.787
  21. Gözalan A, Ünaldi O, Kirca F, Çöplü N, Müderris T, Açikgöz Z, et al. Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Blood Culture Isolates from Three Hospitals in Turkey. Jpn J Infect Dis. 2021;74(3):200–8. doi: 10.7883/yoken.JJID.2020.478
  22. Ramadan R.A GMG, Kadry H.M, Mosallem A. Carbapenem-resistant Acinetobacter baumannii, and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations. Infect Drug Resist. 2018;11:1261–9. doi: 10.2147/IDR.S170233
  23. Alcántar-Curiel MD, Rosales-Reyes R, Jarillo-Quijada MD, Gayosso-Vázquez C, Fernández-Vázquez JL, Toledano-Tableros JE, et al. Carbapenem-Resistant Acinetobacter baumannii in Three Tertiary Care Hospitals in Mexico: Virulence Profiles, Innate Immune Response and Clonal Dissemination. Front Microbiol. 2019;10:2116. doi:10.3389/fmicb.2019.02116
  24. Noori M, Karimi A, Fallah F, Hashemi A, Alimehr S, Goudarzi H, et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii isolated from two hospitals in Tehran, Iran. Arch Pediatr Infect Dis. 2014;2(3):e15439. https://doi.org/10.5812/pedinfect.15439
  25. Kirtikliene T, Mierauskaitė A, Razmienė I, Kuisiene N. Multidrug-Resistant Acinetobacter baumannii Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018. Life. 2021;11(2):151. doi:10.3390/life11020151
  26. Mohammad Hamidian, Ruth M. Hall, Resistance to third-generation cephalosporins in Acinetobacter baumannii due to horizontal transfer of a chromosomal segment containing ISAba1-ampC. J Antimicrob Chemother. 2014;69(10):2865–66. DOI 10.1093/jac/dku202.
  27. Yao Y, Chen Q, Zhou H. Virulence Factors and Pathogenicity Mechanisms of Acinetobacter baumannii in Respiratory Infectious Diseases. Antibiotics (Basel). 2023;12(12):1749. doi:10.3390/antibiotics12121749.




DOI: https://doi.org/10.15395/mkb.v56.3794

Article Metrics

Abstract view : 121 times
PDF - 12 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats